Novartis (United States) (Q331560)

From geokb

company organization in New York, United States

NPC

Language	Label	Description	Also known as
English	Novartis (United States)	company organization in New York, United States	NPC

Statements

0 references

addresses subject

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

479

1 reference

https://openalex.org/I4210117619

Efficacy and Resistance in CML Treatment

476

1 reference

https://openalex.org/I4210117619

417

1 reference

https://openalex.org/I4210117619

Health Economics and Quality of Life Assessment

369

1 reference

https://openalex.org/I4210117619

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

332

1 reference

https://openalex.org/I4210117619

Diagnosis and Treatment of Heart Failure

332

1 reference

https://openalex.org/I4210117619

Computational Methods in Drug Discovery

311

1 reference

https://openalex.org/I4210117619

Chimeric Antigen Receptor T Cell Therapy

291

1 reference

https://openalex.org/I4210117619

Classification and Treatment of Spondyloarthritis

285

1 reference

https://openalex.org/I4210117619

Management of Hypertension and Cardiovascular Risk Factors

284

1 reference

https://openalex.org/I4210117619

Reciprocal Development of TH17 and Treg Cells

278

1 reference

https://openalex.org/I4210117619

Standardisation and Management of COPD

267

1 reference

https://openalex.org/I4210117619

Statistical Methods in Clinical Trials and Drug Development

258

1 reference

https://openalex.org/I4210117619

Genetic and Clinical Aspects of Hemoglobin Disorders

257

1 reference

https://openalex.org/I4210117619

Rheumatoid Arthritis Topics

235

1 reference

https://openalex.org/I4210117619

Advancements in Lung Cancer Research

235

1 reference

https://openalex.org/I4210117619

Hemophagocytic Lymphohistiocytosis and Related Disorders

233

1 reference

https://openalex.org/I4210117619

HER2 Signaling in Breast Cancer Treatment

226

1 reference

https://openalex.org/I4210117619

Management of Diabetes Mellitus and Cardiovascular Risk

217

1 reference

https://openalex.org/I4210117619

Acute Myeloid Leukemia

215

1 reference

https://openalex.org/I4210117619

Role of Fibroblast Activation in Cancer Progression

206

1 reference

https://openalex.org/I4210117619

Genomic Landscape of Cancer and Mutational Signatures

203

1 reference

https://openalex.org/I4210117619

Epidemiology and Treatment of Childhood Leukemia

200

1 reference

https://openalex.org/I4210117619

Pulmonary Drug Delivery Techniques

196

1 reference

https://openalex.org/I4210117619

Drug Metabolism and Pharmacogenomics

196

1 reference

https://openalex.org/I4210117619

coordinate location

40°42'51"N, 74°0'21"W

1 reference

https://openalex.org/I4210117619

United States of America

1 reference

https://openalex.org/I4210117619

official website

https://www.novartis.us/

1 reference

https://openalex.org/I4210117619

0 references

Research Organization Registry ID

0 references

is subsidiary of

Novartis (Switzerland)

1 reference

https://openalex.org/I4210117619

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331560&oldid=1267980"